Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

01-12-2021 | Atrial Fibrillation | Research

Decreased estimated glomerular filtration rate predicts long-term recurrence after catheter ablation of atrial fibrillation in mild to moderate renal insufficiency

Authors: Jing Zheng, Deling Zu, Keyun Cheng, Yunlong Xia, Yingxue Dong, Zhenyan Gao

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

Catheter ablation is an established therapy for atrial fibrillation (AF), but recurrence after ablation remains a great challenge. Additionally, little is known about the effect of renal function on the efficiency of AF ablation. This study aimed to evaluate the predictors of the prognosis of catheter ablation for AF, especially the effect of renal function.

Methods

A total of 306 drug-refractory symptomatic patients with AF who underwent first-time catheter ablation were enrolled in the present study. Individuals underwent circumferential pulmonary vein isolation for paroxysmal AF and stepwise ablation for persistent AF.

Results

The follow-up time was 27.2 ± 19.5 months, 202 patients (66.01%) were free of atrial tachyarrhythmia (non-recurrence group), and the other 104 patients experienced recurrence (recurrence group). The recurrence group had a larger left atrial diameter (LAD) and left atrial volume (LAV), a higher LAV index (LAVI) (both, p < 0.01), and a lower estimated glomerular filtration rate (eGFR) (53.5 ± 14.4 vs. 65.5 ± 13.3 ml/min/1.732, p < 0.001) and creatinine clearance rate (CCr) (85.2 ± 26.1 vs. 101.5 ± 29.4 ml/min, p < 0.05). Multivariate logistic regression indicated both eGFR (p = 0.002) and LAVI (p < 0.001) as independent associated factors for long-term recurrence after single catheter ablation; multivariate Cox proportional hazard regression with backward feature selection identified both eGFR (HR: 0.93, 95% CI: 0.91–0.95, p < 0.001) and LAVI (HR: 1.32, 95% CI: 1.25–1.40, p < 0.001) as independent prognostic factors for recurrence when adjusting other clinical variables.

Conclusions

Decreased eGFR and elevated LAVI may facilitate the long-term recurrence of atrial tachyarrhythmia after catheter ablation for AF.
Literature
1.
go back to reference Joseph PG, Healey JS, Raina P, et al. Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153, 152 middle-aged individuals. Cardiovasc Res. 2020;117:cvaa241. Joseph PG, Healey JS, Raina P, et al. Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153, 152 middle-aged individuals. Cardiovasc Res. 2020;117:cvaa241.
2.
go back to reference Vinter N, Huang Q, Fenger-Grøn M, et al. Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study. BMJ. 2020;370:m2724.PubMedPubMedCentralCrossRef Vinter N, Huang Q, Fenger-Grøn M, et al. Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study. BMJ. 2020;370:m2724.PubMedPubMedCentralCrossRef
3.
go back to reference Lee KJ, Kim BJ, Han MK, et al. Effect of heart rate on stroke recurrence and mortality in acute ischemic stroke with atrial fibrillation. Stroke. 2020;51(1):162–9.PubMedCrossRef Lee KJ, Kim BJ, Han MK, et al. Effect of heart rate on stroke recurrence and mortality in acute ischemic stroke with atrial fibrillation. Stroke. 2020;51(1):162–9.PubMedCrossRef
4.
go back to reference Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–8.PubMedCrossRef Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–8.PubMedCrossRef
5.
go back to reference Poole JE, Bahnson TD, Monahan KH, et al. Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA trial. J Am Coll Cardiol. 2020;75(25):3105–18.PubMedPubMedCentralCrossRef Poole JE, Bahnson TD, Monahan KH, et al. Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA trial. J Am Coll Cardiol. 2020;75(25):3105–18.PubMedPubMedCentralCrossRef
6.
go back to reference Guo Y, Gao J, Ye P, et al. Comparison of atrial fibrillation in CKD and non-CKD populations: a cross-sectional analysis from the Kailuan study. Int J Cardiol. 2019;15(277):125–9.CrossRef Guo Y, Gao J, Ye P, et al. Comparison of atrial fibrillation in CKD and non-CKD populations: a cross-sectional analysis from the Kailuan study. Int J Cardiol. 2019;15(277):125–9.CrossRef
7.
go back to reference Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461–70.PubMedCrossRef Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461–70.PubMedCrossRef
8.
go back to reference Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.PubMedCrossRef Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.PubMedCrossRef
9.
go back to reference Lang RM, Bierig M, Devereux RB, et al. American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology: recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108.PubMedCrossRef Lang RM, Bierig M, Devereux RB, et al. American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology: recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108.PubMedCrossRef
10.
go back to reference Du Bois D. A formula to estimate the approximate surface area if height and weight be known. Nutrition. 1989;5:303–11.PubMed Du Bois D. A formula to estimate the approximate surface area if height and weight be known. Nutrition. 1989;5:303–11.PubMed
11.
go back to reference Chao TF, Lin YJ, Tsao HM, et al. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol. 2011;58:2380–5.PubMedCrossRef Chao TF, Lin YJ, Tsao HM, et al. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol. 2011;58:2380–5.PubMedCrossRef
12.
go back to reference Piccini JP, Stevens SR, Chang Y, et al. ROCKET AF Steering Committee and Investigators: Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation. 2013;127:224–32.PubMedCrossRef Piccini JP, Stevens SR, Chang Y, et al. ROCKET AF Steering Committee and Investigators: Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation. 2013;127:224–32.PubMedCrossRef
13.
go back to reference Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, Iesaka Y. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2007;4(6):816–61.PubMedCrossRef Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, Iesaka Y. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2007;4(6):816–61.PubMedCrossRef
14.
go back to reference Caldentey G, Khairy P, Roy D, et al. Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF Trial (Atrial Fibrillation and Chronic Heart Failure). JACC Heart Fail. 2014;2:15–23.PubMedCrossRef Caldentey G, Khairy P, Roy D, et al. Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF Trial (Atrial Fibrillation and Chronic Heart Failure). JACC Heart Fail. 2014;2:15–23.PubMedCrossRef
15.
go back to reference Thacker EL, McKnight B, Psaty BM, et al. Association of body mass index, diabetes, hypertension, and blood pressure levels with risk of permanent atrial fibrillation. J Gen Intern Med. 2013;28:247–53.PubMedCrossRef Thacker EL, McKnight B, Psaty BM, et al. Association of body mass index, diabetes, hypertension, and blood pressure levels with risk of permanent atrial fibrillation. J Gen Intern Med. 2013;28:247–53.PubMedCrossRef
16.
go back to reference Voskoboinik A, et al. Alcohol abstinence in drinkers with atrial fibrillation. N Engl J Med. 2020;382(1):20–8.PubMedCrossRef Voskoboinik A, et al. Alcohol abstinence in drinkers with atrial fibrillation. N Engl J Med. 2020;382(1):20–8.PubMedCrossRef
17.
go back to reference Cove CL, Albert CM, Andreotti F, et al. Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb Haemost. 2014;111:385–91.PubMedCrossRef Cove CL, Albert CM, Andreotti F, et al. Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb Haemost. 2014;111:385–91.PubMedCrossRef
18.
go back to reference Chao TF, Liu CJ, Chen SJ, et al. CHADS2 score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan. Int J Cardiol. 2013;168:1360–3.PubMedCrossRef Chao TF, Liu CJ, Chen SJ, et al. CHADS2 score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan. Int J Cardiol. 2013;168:1360–3.PubMedCrossRef
19.
go back to reference Bai Y, Liu N, Bai R, Wu JH, et al. Impacts of radiofrequency ablation on quality of life of atrial fibrillation patients with low CHA2DS2-VASc score. Zhonghua Nei Ke Za Zhi. 2016;55(4):278–82.PubMed Bai Y, Liu N, Bai R, Wu JH, et al. Impacts of radiofrequency ablation on quality of life of atrial fibrillation patients with low CHA2DS2-VASc score. Zhonghua Nei Ke Za Zhi. 2016;55(4):278–82.PubMed
20.
go back to reference Kornej J, Hindricks G, Kosiuk J, et al. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Circ Arrhythm Electrophysiol. 2014;7:281–7.PubMedCrossRef Kornej J, Hindricks G, Kosiuk J, et al. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Circ Arrhythm Electrophysiol. 2014;7:281–7.PubMedCrossRef
21.
go back to reference Letsas KP, Efremidis M, Giannopoulos G, et al. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Europace. 2014;16:202–7.PubMedCrossRef Letsas KP, Efremidis M, Giannopoulos G, et al. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Europace. 2014;16:202–7.PubMedCrossRef
22.
go back to reference Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–35.PubMedCrossRef Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713–35.PubMedCrossRef
23.
go back to reference Iwasaki Y, Sawada T, Kijima H, et al. Estimated glomerular filtration rate is superior to measured creatinine clearance for predicting postoperative renal dysfunction in patients undergoing pancreatoduodenectomy. Pancreas. 2010;39:20–5.PubMedCrossRef Iwasaki Y, Sawada T, Kijima H, et al. Estimated glomerular filtration rate is superior to measured creatinine clearance for predicting postoperative renal dysfunction in patients undergoing pancreatoduodenectomy. Pancreas. 2010;39:20–5.PubMedCrossRef
24.
25.
go back to reference Baber U, Howard VJ, Halperin JL, et al. Association of chronic kidney disease with atrial fibrillation among adults in the United States REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Circ Arrhythm Electrophysiol. 2011;4:26–32.PubMedCrossRef Baber U, Howard VJ, Halperin JL, et al. Association of chronic kidney disease with atrial fibrillation among adults in the United States REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Circ Arrhythm Electrophysiol. 2011;4:26–32.PubMedCrossRef
26.
go back to reference Meyer C, Schueller P, Balzer J, et al. Sympathetic hyperactivity influences chemosensor function in patients with end-stage renal disease. Eur J Med Res. 2009;14:151–5.PubMedPubMedCentralCrossRef Meyer C, Schueller P, Balzer J, et al. Sympathetic hyperactivity influences chemosensor function in patients with end-stage renal disease. Eur J Med Res. 2009;14:151–5.PubMedPubMedCentralCrossRef
28.
go back to reference McCullough PA, Kellum JA, Haase M, et al. Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;182:82–98.PubMedCrossRef McCullough PA, Kellum JA, Haase M, et al. Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;182:82–98.PubMedCrossRef
29.
go back to reference Potpara ST, Jokic V, Dagres N, Marin F, Prostran SM, et al. Cardiac arrhythmias in patients with chronic kidney disease: implications of renal failure for antiarrhythmic drug therapy. Curr Med Chem. 2016;23(19):2070–83.PubMedCrossRef Potpara ST, Jokic V, Dagres N, Marin F, Prostran SM, et al. Cardiac arrhythmias in patients with chronic kidney disease: implications of renal failure for antiarrhythmic drug therapy. Curr Med Chem. 2016;23(19):2070–83.PubMedCrossRef
30.
go back to reference Patterson E, Lazzara R, Szabo B, et al. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmiatrigger within pulmonary veins. J Am Coll Cardiol. 2006;47:1196–206.PubMedCrossRef Patterson E, Lazzara R, Szabo B, et al. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmiatrigger within pulmonary veins. J Am Coll Cardiol. 2006;47:1196–206.PubMedCrossRef
31.
go back to reference Oral H, Crawford T, Frederick M, et al. Inducibility of paroxysmal atrial fibrillation by isoproterenol and its relation to the mode of onset of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19:466–70.PubMedCrossRef Oral H, Crawford T, Frederick M, et al. Inducibility of paroxysmal atrial fibrillation by isoproterenol and its relation to the mode of onset of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19:466–70.PubMedCrossRef
32.
go back to reference Tsai CF, Yang SF, Chu HJ, Ueng KC. Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes. Int J Cardiol. 2013;169:17–28.PubMedCrossRef Tsai CF, Yang SF, Chu HJ, Ueng KC. Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes. Int J Cardiol. 2013;169:17–28.PubMedCrossRef
33.
go back to reference Mayyas F, Alzoubi KH, Van Wagoner DR. Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodelling. Int J Cardiol. 2013;168:5135–42.PubMedPubMedCentralCrossRef Mayyas F, Alzoubi KH, Van Wagoner DR. Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodelling. Int J Cardiol. 2013;168:5135–42.PubMedPubMedCentralCrossRef
34.
go back to reference Perrier R, Richard S, Sainte-Marie Y, et al. A direct relationship between plasma aldosterone and cardiac L-type Ca2+ current in mice. J Physiol. 2005;569:153–62.PubMedPubMedCentralCrossRef Perrier R, Richard S, Sainte-Marie Y, et al. A direct relationship between plasma aldosterone and cardiac L-type Ca2+ current in mice. J Physiol. 2005;569:153–62.PubMedPubMedCentralCrossRef
35.
go back to reference Pan J, Wang W, Wu X, et al. Inflammatory cytokines in cardiac pacing patients with atrial fibrillation and asymptomatic atrial fibrillation. Panminerva Med. 2018;60(3):86–91.PubMedCrossRef Pan J, Wang W, Wu X, et al. Inflammatory cytokines in cardiac pacing patients with atrial fibrillation and asymptomatic atrial fibrillation. Panminerva Med. 2018;60(3):86–91.PubMedCrossRef
36.
go back to reference Macisaac RJ, Ekinci EI, Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease. Am J Kidney Dis. 2014;63(2):S39–62.PubMedCrossRef Macisaac RJ, Ekinci EI, Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease. Am J Kidney Dis. 2014;63(2):S39–62.PubMedCrossRef
37.
go back to reference Lim HS, Schultz C, Dang J, et al. Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:83–9.PubMedCrossRef Lim HS, Schultz C, Dang J, et al. Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:83–9.PubMedCrossRef
38.
go back to reference Toyama K, Yamabe H, Uemura T, et al. Analysis of oxidative stress expressed by urinary level of 8-hydroxy-2’-deoxyguanosine and biopyrrin in atrial fibrillation: effect of sinus rhythm restoration. Int J Cardiol. 2013;168:80–5.PubMedCrossRef Toyama K, Yamabe H, Uemura T, et al. Analysis of oxidative stress expressed by urinary level of 8-hydroxy-2’-deoxyguanosine and biopyrrin in atrial fibrillation: effect of sinus rhythm restoration. Int J Cardiol. 2013;168:80–5.PubMedCrossRef
39.
go back to reference Teh AW, Kistler PM, Lee G, et al. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease. J Cardiovasc Electrophysiol. 2012;23:232–8.PubMedCrossRef Teh AW, Kistler PM, Lee G, et al. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease. J Cardiovasc Electrophysiol. 2012;23:232–8.PubMedCrossRef
40.
go back to reference Akkaya M, Higuchi K, Koopmann M, et al. Higher degree of left atrial structural remodeling in patients with atrial fibrillation and left ventricular systolic dysfunction. J Cardiovasc Electrophysiol. 2013;24:485–91.PubMedCrossRef Akkaya M, Higuchi K, Koopmann M, et al. Higher degree of left atrial structural remodeling in patients with atrial fibrillation and left ventricular systolic dysfunction. J Cardiovasc Electrophysiol. 2013;24:485–91.PubMedCrossRef
41.
go back to reference Guichard JB, Naud P, Xiong F, et al. Comparison of atrial remodeling caused by sustained atrial flutter versus atrial fibrillation. JACC. 2020;76(4):374–88.PubMedCrossRef Guichard JB, Naud P, Xiong F, et al. Comparison of atrial remodeling caused by sustained atrial flutter versus atrial fibrillation. JACC. 2020;76(4):374–88.PubMedCrossRef
42.
go back to reference Park J, Joung B, Uhm JS, et al. High left atrial pressures are associated with advanced electroanatomical remodeling of left atrium and independent predictors for clinical recurrence of atrial fibrillation after catheter ablation. Heart Rhythm. 2014;11:953–60.PubMedCrossRef Park J, Joung B, Uhm JS, et al. High left atrial pressures are associated with advanced electroanatomical remodeling of left atrium and independent predictors for clinical recurrence of atrial fibrillation after catheter ablation. Heart Rhythm. 2014;11:953–60.PubMedCrossRef
43.
go back to reference Ejima K, Kato K, Arai K, et al. Impact of atrial remodeling on the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation. Circ J. 2014;78:872–7.PubMedCrossRef Ejima K, Kato K, Arai K, et al. Impact of atrial remodeling on the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation. Circ J. 2014;78:872–7.PubMedCrossRef
44.
go back to reference Lee H-L, Hwang Y-T, Chang P-C, et al. A three-year longitudinal study of the relation between left atrial diameter remodeling and atrial fibrillation ablation outcome. J Geriatr Cardiol. 2018;15(7):486–91.PubMedPubMedCentral Lee H-L, Hwang Y-T, Chang P-C, et al. A three-year longitudinal study of the relation between left atrial diameter remodeling and atrial fibrillation ablation outcome. J Geriatr Cardiol. 2018;15(7):486–91.PubMedPubMedCentral
45.
go back to reference Marchese P, Malavasi V, Rossi L, et al. Indexed left atrial volume is superior to left atrial diameter in predicting nonvalvular atrial fibrillation recurrence after successful cardioversion: a prospective study. Echocardiography. 2012;29:276–84.PubMedCrossRef Marchese P, Malavasi V, Rossi L, et al. Indexed left atrial volume is superior to left atrial diameter in predicting nonvalvular atrial fibrillation recurrence after successful cardioversion: a prospective study. Echocardiography. 2012;29:276–84.PubMedCrossRef
46.
go back to reference Kataoka T, Hamasaki S, Inoue K, et al. Left atrium volume index and pathological features of left atrial appendage as a predictor of failure in postoperative sinus conversion. J Cardiol. 2010;55:274–82.PubMedCrossRef Kataoka T, Hamasaki S, Inoue K, et al. Left atrium volume index and pathological features of left atrial appendage as a predictor of failure in postoperative sinus conversion. J Cardiol. 2010;55:274–82.PubMedCrossRef
47.
go back to reference Guo Y, Lane DA, Wang L, et al. Mobile health technology to improve care for patients with atrial fibrillation. J Am Coll Cardiol. 2020;75(13):1523–34.PubMedCrossRef Guo Y, Lane DA, Wang L, et al. Mobile health technology to improve care for patients with atrial fibrillation. J Am Coll Cardiol. 2020;75(13):1523–34.PubMedCrossRef
Metadata
Title
Decreased estimated glomerular filtration rate predicts long-term recurrence after catheter ablation of atrial fibrillation in mild to moderate renal insufficiency
Authors
Jing Zheng
Deling Zu
Keyun Cheng
Yunlong Xia
Yingxue Dong
Zhenyan Gao
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02320-y

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue